R&D Toolboxes

iBET has a vast expertise in the development and application of
state-of-the art assays and bioanalytical tools to assess critical
quality attributes of biological products, compatible with technology
transfer under R&D and GMP conditions.

iBET’s Late-Stage and Bioproduction Unit has over 30 years of experience in advancing integrated bioprocesses and analytical methods for the production, purification and characterization of complex biologics, especially recombinant proteins, gene and cell-based products, and vaccines.

To address the growing demands of the industry, our unit provides tailored solutions for biotechs, CDMOs and large pharmaceutical companies, focusing on Bioprocess and Bioanalytics Development, GMP-compliant Bioprocess Scale-up, and Technology Transfer.

The institute has over 30 years of experience in developing integrated bioprocesses and analytical methods for the production, purification and characterization of complex biopharmaceuticals including recombinant proteins such as antigens and antibodies.

iBET’s extensive RD&I pipeline encompasses several stages of Omics studies, from sample preparation and data analysis to biological interpretation.

This is supported by over 30+ years of experience in bioprocess and analytics development for the production of Biopharmaceuticals, ATMPs (including gene and cell-based therapies), and Vaccines.

We currently develop projects with Proteomics, Metabolomics & Fluxomics, and Transcriptomics.